Rock Creek Pharmaceuticals, Inc., known as Star Scientific, Inc. until its rebranding in June 2014, was a pharmaceutical development enterprise. Its primary objective was the discovery, advancement, and market introduction of therapeutic solutions for persistent inflammatory diseases and neurological conditions. The company's most prominent drug candidate, Anatabine citrate, is a small-molecule cholinergic agonist that demonstrates unique anti-inflammatory pharmacological attributes.